ISDS Case Map
intellectual property
The Central American Free Trade agreement faces skepticism and negative sentiment in countries working to implement the pact.
The Thai-US free-trade talks hit a snag yesterday after the head Thai negotiator for intellectual-property rights declared demands by the US for Thailand to tighten up drug patenting as “unacceptable”.
Thai AIDS activists and their international allies are
seeking suspension of scheduled trade talks that threaten to undermine
Thailand's lawful ability to produce, import/export, and market low-cost
generic versions of life-saving medicines.
Thailand should think carefully about surrendering its sovereign rights under the WTO -- and access to cheap medicine -- in exchange for an FTA with the United States
The atmosphere is ripe for starting talks with the United States for a tariff-free trade scheme, which, if realized, may change this country's overall industrial picture as never before. But an FTA with giant, advanced economies, like America's, requires a very careful approach.
Rallies against free-trade talks between Thai and US officials today are set to draw a record number of protesters. Here are the reasons for this given by some planning to attend the protests.
A leading academic says there is no reason why Thailand should offer terms of
intellectual property rights (IPR) protection beyond what's available within the US legal framework.
in December 2005 3D published a country briefing entitled “International trade, health and children's rights - Thailand” which raises concerns regarding Thailand's Free Trade Agreement (FTA) negotiations and their impact on children's rights.
Civil society sector is demanding that the Thai government not give in on reduction of tariffs for US agricultural product, not ratify the treaty on plant varieties protection, and not recognise patenting of biological resources. In addition, they said the Thai government must resist the US demand to extend protection of pharmaceutical patent to more than 20 years or to protect data exclusivity.
An official from Thailand's bilateral Free Trade Agreement negotiating team today disputed claims by opposition groups that a free trade agreement with the US would adversely affect the country's prescription drug market.
